Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size

Dirkje S. Postma; Alan Kaplan; Joan B. Soriano; Jonathon Grigg; Theresa W. Guilbert; Wim van Aalderen; Nicolas Roche; Anne Burden; Elizabeth V. Hillyer; Elliot Israel; David B. Price

doi:10.1007/s41030-017-0037-3

Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size

Dirkje S. Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg, Theresa W. Guilbert, Wim van Aalderen, Nicolas Roche, Anne Burden, Elizabeth V. Hillyer, Elliot Israel, David B. Price

Research output: Contribution to journal › Article › peer-review

5 Downloads (Pure)

Abstract

Targeting small airway inflammation could lead to improved clinical outcomes in asthma. Previous observational studies concluded that therapy with extrafine-particle [mass median aerodynamic diameter (MMAD)

Original language	English
Pages (from-to)	113-124
Number of pages	12
Journal	Pulmonary Therapy
Volume	3
Issue number	1
Early online date	12 Apr 2017
DOIs	https://doi.org/10.1007/s41030-017-0037-3
Publication status	Published - Jun 2017

Keywords

dose response
particle size
real-life research
beclomethasone dipropionate
Fluticasone propionate

Access to Document

10.1007/s41030-017-0037-3Licence: CC BY-NC

Cohort Analysis of Exacerbation Rates in Adolescent
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Final published version, 606 KBLicence: CC BY-NC

Fingerprint Dive into the research topics of 'Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size'. Together they form a unique fingerprint.

Cite this

Postma, D. S., Kaplan, A., Soriano, J. B., Grigg, J., Guilbert, T. W., van Aalderen, W., Roche, N., Burden, A., Hillyer, E. V., Israel, E., & Price, D. B. (2017). Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size. Pulmonary Therapy, 3(1), 113-124. https://doi.org/10.1007/s41030-017-0037-3

Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma : Different Dose–Response Profile by Particle Size. / Postma, Dirkje S.; Kaplan, Alan; Soriano, Joan B.; Grigg, Jonathon; Guilbert, Theresa W.; van Aalderen, Wim; Roche, Nicolas; Burden, Anne; Hillyer, Elizabeth V.; Israel, Elliot; Price, David B.

In: Pulmonary Therapy, Vol. 3, No. 1, 06.2017, p. 113-124.

Research output: Contribution to journal › Article › peer-review

Postma, DS, Kaplan, A, Soriano, JB, Grigg, J, Guilbert, TW, van Aalderen, W, Roche, N, Burden, A, Hillyer, EV, Israel, E & Price, DB 2017, 'Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size', Pulmonary Therapy, vol. 3, no. 1, pp. 113-124. https://doi.org/10.1007/s41030-017-0037-3

Postma, Dirkje S. ; Kaplan, Alan ; Soriano, Joan B. ; Grigg, Jonathon ; Guilbert, Theresa W. ; van Aalderen, Wim ; Roche, Nicolas ; Burden, Anne ; Hillyer, Elizabeth V. ; Israel, Elliot ; Price, David B. / Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma : Different Dose–Response Profile by Particle Size. In: Pulmonary Therapy. 2017 ; Vol. 3, No. 1. pp. 113-124.

@article{0d1cebb6de0847f0aa7ca3e6f49f1774,

title = "Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size",

abstract = "Targeting small airway inflammation could lead to improved clinical outcomes in asthma. Previous observational studies concluded that therapy with extrafine-particle [mass median aerodynamic diameter (MMAD) ",

keywords = "dose response, particle size, real-life research, beclomethasone dipropionate, Fluticasone propionate",

author = "Postma, {Dirkje S.} and Alan Kaplan and Soriano, {Joan B.} and Jonathon Grigg and Guilbert, {Theresa W.} and {van Aalderen}, Wim and Nicolas Roche and Anne Burden and Hillyer, {Elizabeth V.} and Elliot Israel and Price, {David B.}",

note = "Data Availability. The datasets analyzed during the current study are available from the corresponding author on reasonable request. Funding. Teva Pharmaceuticals Europe B.V.",

year = "2017",

month = jun,

doi = "10.1007/s41030-017-0037-3",

language = "English",

volume = "3",

pages = "113--124",

journal = "Pulmonary Therapy",

issn = "2364-1746",

publisher = "Springer ",

number = "1",

}

TY - JOUR

T1 - Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma

T2 - Different Dose–Response Profile by Particle Size

AU - Postma, Dirkje S.

AU - Kaplan, Alan

AU - Soriano, Joan B.

AU - Grigg, Jonathon

AU - Guilbert, Theresa W.

AU - van Aalderen, Wim

AU - Roche, Nicolas

AU - Burden, Anne

AU - Hillyer, Elizabeth V.

AU - Israel, Elliot

AU - Price, David B.

N1 - Data Availability. The datasets analyzed during the current study are available from the corresponding author on reasonable request. Funding. Teva Pharmaceuticals Europe B.V.

PY - 2017/6

Y1 - 2017/6

N2 - Targeting small airway inflammation could lead to improved clinical outcomes in asthma. Previous observational studies concluded that therapy with extrafine-particle [mass median aerodynamic diameter (MMAD)

AB - Targeting small airway inflammation could lead to improved clinical outcomes in asthma. Previous observational studies concluded that therapy with extrafine-particle [mass median aerodynamic diameter (MMAD)

KW - dose response

KW - particle size

KW - real-life research

KW - beclomethasone dipropionate

KW - Fluticasone propionate

U2 - 10.1007/s41030-017-0037-3

DO - 10.1007/s41030-017-0037-3

M3 - Article

VL - 3

SP - 113

EP - 124

JO - Pulmonary Therapy

JF - Pulmonary Therapy

SN - 2364-1746

IS - 1

ER -